Lexaria Bioscience (LEXXW) Stock Chart & Stock Price History $0.12 -0.03 (-20.26%) As of 08/21/2025 03:05 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Stock Price Performance The Lexaria Bioscience (LEXXW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.31%, with a year-to-date return of -84.70%. In the past month, the stock has decreased 21.65%, reflecting recent market activity. As of the latest close, Lexaria Bioscience traded at $0.12 with a market cap of and volume of 586 shares. Receive LEXXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+30.03%1 Month Performance-21.65%3 Month Performance-32.82%Year-To-Date Performance-84.70%1 Year Performance-88.31% LEXXW Stock Chart for Friday, August, 22, 2025 LEXXW Chart by TradingView Lexaria Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.15$0.12-20.26%$0.12$0.12586 shs$0.0008/20/2025$0.15$0.15$0.15$0.151,500 shs$0.0008/19/2025$0.13$0.15+10.31%$0.15$0.151,547 shs$0.0008/18/2025$0.09$0.13+47.83%$0.13$0.131,000 shs$0.0008/15/2025$0.09$0.09-0.22%$0.09$0.091,446 shs$0.0008/14/2025$0.11$0.09-18.31%$0.14$0.092,151 shs$0.0008/13/2025$0.11$0.11$0.13$0.112,200 shs$0.0008/12/2025$0.13$0.11-15.15%$0.13$0.112,203 shs$0.0008/11/2025$0.14$0.13-6.61%$0.13$0.13300 shs$0.0008/08/2025$0.11$0.14+31.32%$0.14$0.11306 shs$0.00 Get the Latest News and Ratings for LEXXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.11$0.11$0.12$0.101,100 shs$0.0008/06/2025$0.13$0.11-18.46%$0.12$0.101,130 shs$0.0008/05/2025$0.13$0.13$0.14$0.131,100 shs$0.0008/04/2025$0.14$0.13-6.88%$0.14$0.131,100 shs$0.0008/01/2025$0.12$0.14+16.33%$0.14$0.101,700 shs$0.0007/31/2025$0.12$0.12$0.12$0.12100 shs$0.0007/30/2025$0.12$0.12$0.12$0.12100 shs$0.0007/29/2025$0.10$0.12+20.00%$0.12$0.12277 shs$0.0007/28/2025$0.10$0.10$0.15$0.101,640 shs$0.0007/25/2025$0.15$0.10-32.98%$0.15$0.101,640 shs$0.0007/24/2025$0.15$0.15$0.15$0.07300 shs$0.0007/23/2025$0.15$0.15$0.15$0.07300 shs$0.0007/22/2025$0.15$0.15-0.53%$0.15$0.07300 shs$0.0007/21/2025$0.15$0.15$0.15$0.15395 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart ARAVIVE Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Receive LEXXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXXW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access